2-Phenyl-1-(2-thioxothiazolidin-3-yl)ethan-1-one, 95%, 1g

4-(Pyrimidin-2-yloxy)benzonitrile, 95.0%, 10g

1-(3,4-Difluorophenyl)cyclopropane-1-carboxylic acid, 97%, 1g

Benzonitrile, 2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl]-, 95%, 1g

3,5-Dichloro-4-ethoxybenzoic acid, 98%, 1g

1-Bromo-3-chloro-5-methoxybenzene, 95.0%, 25g

Moexipril hydrochloride, 98%, 250mg

(4-Amino-3-nitrophenyl)boronic acid, 95.0%, 100mg

(3-AMINO-6-METHYLPYRIDIN-2-YL)METHANOL, 95.0%, 250mg

tert-Butyl (2-(4-nitrophenoxy)ethyl)carbamate, 95.0%, 5g

HPTLC Plates RP-18 W / UV254 - octadecyl-modified, 20 x 20 cm, 1.00 mm, 15 Piece(s)

1-(7-Chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid, 97%, 50mg

5-(3-Methoxy-phenyl)-[1,2,4]triazin-3-ylamine, 1g